ChainGen Bio

BiotechnologySeries BShanghai, China

Latest round

Series B

Last raised

Dec 2025

Total raised

Undisclosed

Investors

7

About ChainGen Bio

, Ltd, trading as Jiajin Biology, is a biotechnology company that focuses on drug coupling and delivery technologies. The founder and CEO, Hao Wu, graduated from Tsinghua University has worked for NGM, Novo Nordisk, WuXi Biologics, and other companies. The company specializes in the field of antibody-small nucleic acid coupled drugs and in-brain delivery which mainly develops drugs for genetic disorders of the neuromuscular system. The core pipeline focuses on two indications, DM1 and DMD. It has developed a brain-entry peptide Brainferry platform that can be applied in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The company generates revenue by providing antibody-small nucleic acid coupled drugs and an in-brain delivery platform.

Who invested in ChainGen Bio

7 investors across 3 rounds

See all investors in ChainGen Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Dec 29, 2025

    Amount

    Undisclosed

    Investors

    Locked

  2. Series B

    Aug 20, 2025

    Amount

    Undisclosed

    Investors

    Locked

  3. Angel

    Nov 9, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about ChainGen Bio

Who invested in ChainGen Bio?

ChainGen Bio has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ChainGen Bio raised?

ChainGen Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did ChainGen Bio last raise money?

ChainGen Bio's most recent round on record is a Series B, in Dec 2025.

What does ChainGen Bio do?

, Ltd, trading as Jiajin Biology, is a biotechnology company that focuses on drug coupling and delivery technologies.

Where is ChainGen Bio headquartered?

ChainGen Bio is headquartered in Shanghai, China.

Which VCs invest in companies like ChainGen Bio?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at ChainGen Bio's stage. Their profiles are linked below.

Raising like ChainGen Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.